Abattis Bioceuticals Corp. (ATTBF) Research

Abattis Bioceuticals Corp. is a Canadian life sciences and biotechnology firm. It specializes in the development and licensing of natural health products, pharmaceuticals, extracts, and various ingredients, serving the biological, nutraceutical, bioceutical, and cosmetic sectors. Among its offerings is 'Comfort,' a cannabinoid-enhanced nutraceutical formulated to alleviate pain and inflammation. Additionally, Abattis delivers Health Canada-approved services specifically for the cannabis industry. Formerly Abattis Biologix Corporation, the company adopted its current name, Abattis Bioceuticals Corporation, in September 2012. Established in 1997, the company's headquarters are located in Vancouver, Canada.

Market snapshot

Symbol
ATTBF
Price
$0.00
Day change
0.00%
Market cap
$20.3K
P/E ratio
-0.01x
52-week range
0.000001-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • ARYx Therapeutics, Inc. (ARYX)
  • Biome Grow Inc. (BIOIF)
  • Cannabis Global, Inc. (CBGL)
  • Psykey, Inc. (CEOS)
  • Instadose Pharma Corp. (INSD)
  • Isodiol International Inc. (ISOLF)
  • Nunzia Pharmaceutical Company (NUNZ)
  • OWC Pharmaceutical Research Corp. (OWCP)

Open Abattis Bioceuticals Corp. (ATTBF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.